In-licensing pipeline candidates and innovative work to enhance vaccine research and portfolio in the biological space

This June, Mr. Phil Kearney will be joining World Vaccine Congress Asia 2013 and will be speaking on the topic "In-licensing pipeline candidates and innovative work to enhance vaccine research and portfolio in the biological space". His talk will cover Merck's licensing model and interests, as well as how implementing in-licensing can act as a strategy to develop innovative vaccines …